Skip to main content
TipRanks
Go Ultimate75% OFF

Actinium Pharmaceuticals (ATNM) Stock Forecast & Price Target

2,294 Followers
See the Price Targets and Ratings of:

ATNM Analyst Ratings

Moderate Buy
2Ratings
2Buy0Hold0Sell
Based on 2 analysts giving stock ratings to Actinium Pharmaceuticals in the past 3 months

ATNM Stock 12 Month Forecast

$3.50▲(113.41% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Actinium Pharmaceuticals in the last 3 months. The average price target is $3.50 with a high forecast of $4.00 and a low forecast of $3.00. The average price target represents a 113.41% change from the last price of $1.64.
Highest Price Target$4.00Average Price Target$3.50Lowest Price Target$3.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for ATNM
Price TargetArticle
H.C. Wainwright$4buy143.90%UpsideReiterated11/11/26
JonesTrading$3buy82.93%UpsideReiterated10/21/26
Maxim Group$5buy204.88%UpsideReiterated04/07/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
MDWDMediwound
OVIDOvid Therapeutics
IMUXImmunic
QUITAchieve Life Sciences
COGTCogent Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Actinium Pharmaceuticals

3 Months
Justin Walsh
Justin WalshJonesTrading
Success Rate11/26 ratings generated profit
42%
Average Return
-5.92%

Copying Justin Walsh's trades and holding each position for 3 Months would result in 42.31% of your transactions generating a profit, with an average return of -5.92% per trade.

1 Year
Joseph Pantginis
Joseph PantginisH.C. Wainwright
Success Rate7/16 ratings generated profit
44%
Average Return
+0.74%

Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 43.75% of your transactions generating a profit, with an average return of +0.74% per trade.

2 Years
Joseph Pantginis
Joseph PantginisH.C. Wainwright
Success Rate10/16 ratings generated profit
63%
Average Return
+10.26%

Copying Joseph Pantginis's trades and holding each position for 2 Years would result in 62.50% of your transactions generating a profit, with an average return of +10.26% per trade.

ATNM Analyst Recommendation Trends

05101520Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for ATNM
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy23255
Buy00000
Hold00000
Sell00000
Strong Sell00000
total23255

In the current month, ATNM has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ATNM average Analyst price target in the past 3 months is 3.50.

ATNM Financial Forecast

$-2$-1.5$-1$-0.5$0Q4 2024Q4 2025Q3 2026
High$-0.22
Consensus$-0.24
Low$-0.27

ATNM Earnings Forecast

Next quarter’s earnings estimate for ATNM is -$0.24 with a range of -$0.27 to -$0.22. The previous quarter’s EPS was -$0.19. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$-1$22,499.5$45,000$67,500.5$90,001Q4 2024Q4 2025Q3 2026
High$0.00
Consensus$0.00
Low$0.00

ATNM Sales Forecast

Next quarter’s sales forecast for ATNM is $0 with a range of $0 to $0. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

ATNM Stock Forecast FAQ

What is ATNM’s average 12-month price target, according to analysts?
Based on analyst ratings, Actinium Pharmaceuticals’s 12-month average price target is $3.50.
What is ATNM’s upside potential, based on the analysts’ average price target?
Actinium Pharmaceuticals has 113.41% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ATNM a Buy, Sell or Hold?
Actinium Pharmaceuticals has a consensus rating of Moderate Buy which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Actinium Pharmaceuticals’s price target?
The average price target for Actinium Pharmaceuticals is $3.50. This is based on 2 12-month price targets, issued in the past 3 months. The highest analyst price target is $4.00, the lowest forecast is $3.00. The average price target represents a 113.41% increase from the current price of $1.64.
What do analysts say about Actinium Pharmaceuticals?
Actinium Pharmaceuticals’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of ATNM?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.